NCT06016686

Brief Summary

This Anchillary project uses a refined technique of ultrasound-guided microneurography of the human cervical vagus nerve, an approach developed by Professor Vaughan Macefield and used safely to-date in 44 prior study participants. The overall goal of this project is to build upon prior data obtained using this approach by undertaking a detailed neurophysiological investigation of the human vagus nerve and to identify the nerve fibers activated during vagal nerve stimulation (VNS) in participants with implanted VNS devices in response to different stimulation parameters. In addition to providing data in unprecedented detail into the physiology of the human vagus nerve, this project will investigate different stimulus intensities, durations and frequencies that differentially excite myelinated and unmyelinated nerve fibers. These results will inform the CSP and guide future development of novel neural interfaces for VNS for various clinical applications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
7mo left

Started Apr 2024

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Apr 2024Dec 2026

First Submitted

Initial submission to the registry

July 10, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

2.8 years

First QC Date

July 10, 2023

Last Update Submit

April 16, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • identify action potential morphology of specific fibers activated by vagal nerve stimulation (VNS)

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module

    4 hours

  • identify ratio of myelinated fibers in specific fibers activated by vagal nerve stimulation (VNS)

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. Whether a nerve fiber is (un)myelinated can be determined by visual inspection. Myelinated fibers typically produce "a positive-going narrow spike profile.

    4 hours

  • physiological identification of the specific fibers activated by vagal nerve stimulation (VNS)

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. use of tracing and nerve recordings analysis to identify the types of nerves

    4 hours

  • identify firing rates of the specific fibers activated by vagal nerve stimulation (VNS)

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. in Hertz

    4 hours

  • identify stimulus current required to activate specific fibers activated by vagal nerve stimulation (VNS)

    assessing vagal nerve activity in epilepsy participants during and in the absence of stimulation. Labchart; spike histogram module. in milli-amps

    4 hours

  • differences in firing rates of cardiac parasympathetic vagal activity

    compare any changes in parasympathetic vagal activity with participants who have not been implanted with a vagal nerve stimulator (Non-VNS Participants). Labchart; spike histogram module. Unit: Hz.

    4 hours

  • Discharge variability of cardiac parasympathetic nerve fibers

    Vagal nerve stimulator device. Coefficient of variation, %

    4 hours

Study Arms (2)

VNS

EXPERIMENTAL

participants with surgically implanted VNS electrodes to treat drug-resistant epilepsy

Other: VNS stimulation and intraneural recordings

non-VNS participants

EXPERIMENTAL

participants without implanted VNS devices

Other: Record multi-unit activity from intraneural sites

Interventions

A minimum of three stimulation frequencies (1, 10 and 30 Hz), each up to 60s in duration, will be delivered via the VNS device. Intraneural recordings proximal or distal to the VNS electrodes during delivery of VNS will be performed. Approximately two to five fascicles will be explored in each nerve.

VNS

Perform a more detailed vagal nerve mapping study by recording from single nerve fibers, including those fibers supplying the heart, lungs, airways and other end-organs. The investigators shall perform functional mapping of the left and right vagus nerves, such as those with cardiac-related and/or respiratory-related neural activity. The research team will also record activity from other nearby fibers to map the differences in neurological behavior in fascicles that control the heart, lungs, airways and other systems.

non-VNS participants

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The participant is greater than or equal to (≥)18 years and is less than or equal to (≤) 40 years of age
  • English speaking
  • Medicare covered or equivalent health insurance from a partner country

You may not qualify if:

  • Pregnant
  • Smokes and is unwilling to abstain from smoking on the day of the experiment.
  • Inability or unwillingness to provide written informed consent.
  • Individuals with difficulty standing unassisted for 5 minutes during the tilt-table testing
  • Individuals found to have a significant carotid artery plaque or intima-media thickness \> 1 mm as assessed by ultrasonography during the ultrasound-screening steps of the study visit
  • Vagus nerve not visible on ultrasound
  • VNS electrodes are not in a suitable location to allow for microelectrode insertion
  • Any other clinical reasons deemed by the investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

RECRUITING

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Vaughan G Macefield, PhD

    Monash University

    PRINCIPAL INVESTIGATOR
  • John Osborn

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kathryn Vera, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2023

First Posted

August 30, 2023

Study Start

April 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 20, 2026

Record last verified: 2026-04

Locations